Assessment of Fosaprepitant and Aprepitant Use as an Independent Risk Factor for Ifosfamide Neurotoxicity

Presenter/Author Information

Anna Clennon PharmD, BCOP, Pharmacy, Aurora St. Luke's Medical Center, Advocate HealthFollow
Mitchell Fisher, Pharmacy, Aurora St. Luke's Medical Center, Advocate HealthFollow
Sol Atienza PharmD, BCOP, Pharmacy, Aurora St. Luke's Medical Center, Advocate HealthFollow

Recommended Citation

Clennon A, Fisher M, Atienza S. Assessment of Fosaprepitant and Aprepitant Use as an Independent Risk Factor for Ifosfamide Neurotoxicity. J Patient Cent Res Rev. 2025;12:257. doi: 10.17294/2330-0698.2248

Affiliations

Aurora St. Luke's Medical Center

Presentation Notes

General poster presented at Scientific Day; May 21, 2025; Park Ridge, IL. https://institutionalrepository.aah.org/sciday/2025/general/15

Document Type

Abstract